The Scientist

» Big Pharma and ecology

Most Recent

image: Owl Be Darned

Owl Be Darned

By | December 4, 2015

Researchers studying city-dwelling birds are learning about which animals are more suited to urban life.

1 Comment

image: A Rainforest Chorus

A Rainforest Chorus

By | December 1, 2015

Researchers measure the health of Papua New Guinea’s forests by analyzing the ecological soundscape.

0 Comments

image: Jungle Field Trip

Jungle Field Trip

By | December 1, 2015

Travel to remote rain forests in Papua New Guinea with researchers from The Nature Conservancy who are working with native people to characterize ecosystems there using sound.

0 Comments

image: Urban Owl-Fitters

Urban Owl-Fitters

By | December 1, 2015

How birds with an innate propensity for living among humans are establishing populations in cities

0 Comments

image: Spiders, Prey Leave DNA

Spiders, Prey Leave DNA

By | November 30, 2015

A study of black widow spiders suggests that the arachnids leave traces of their own genetic material and DNA from prey in their sticky webs.

0 Comments

image: Pfizer and Allergan to Merge

Pfizer and Allergan to Merge

By | November 23, 2015

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

0 Comments

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

image: Buzzed Honeybees

Buzzed Honeybees

By | October 20, 2015

Caffeinated nectar makes bees more loyal to a food source, even when foraging there is suboptimal.

0 Comments

image: One-Third of Cactus Species Threatened

One-Third of Cactus Species Threatened

By | October 6, 2015

A global assessment of declining cacti populations places responsibility on increasing human activities.

0 Comments

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS